332 related articles for article (PubMed ID: 34171436)
1. Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET].
Fernandez-Checa JC; Bagnaninchi P; Ye H; Sancho-Bru P; Falcon-Perez JM; Royo F; Garcia-Ruiz C; Konu O; Miranda J; Lunov O; Dejneka A; Elfick A; McDonald A; Sullivan GJ; Aithal GP; Lucena MI; Andrade RJ; Fromenty B; Kranendonk M; Cubero FJ; Nelson LJ
J Hepatol; 2021 Oct; 75(4):935-959. PubMed ID: 34171436
[TBL] [Abstract][Full Text] [Related]
2. Co-Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver-Chip for the Study of Drug-Induced Liver Injury.
Shi Q; Arefin A; Ren L; Papineau KS; Barnette DA; Schnackenberg LK; Hawes JJ; Avigan M; Mendrick DL; Ewart L; Ronxhi J
Curr Protoc; 2022 Jul; 2(7):e478. PubMed ID: 35790095
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review.
Niu H; Atallah E; Alvarez-Alvarez I; Medina-Caliz I; Aithal GP; Arikan C; Andrade RJ; Lucena MI
Drug Saf; 2022 Nov; 45(11):1329-1348. PubMed ID: 36006605
[TBL] [Abstract][Full Text] [Related]
4. Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network.
Segovia-Zafra A; Villanueva-Paz M; Serras AS; Matilla-Cabello G; Bodoque-García A; Di Zeo-Sánchez DE; Niu H; Álvarez-Álvarez I; Sanz-Villanueva L; Godec S; Milisav I; Bagnaninchi P; Andrade RJ; Lucena MI; Fernández-Checa JC; Cubero FJ; Miranda JP; Nelson LJ
J Hepatol; 2024 May; ():. PubMed ID: 38703829
[TBL] [Abstract][Full Text] [Related]
5. Acetaminophen: Dose-Dependent Drug Hepatotoxicity and Acute Liver Failure in Patients.
Jaeschke H
Dig Dis; 2015; 33(4):464-71. PubMed ID: 26159260
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients.
McGill MR; Jaeschke H
Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):1005-17. PubMed ID: 24836926
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of drug-induced liver injury: a mechanistic perspective through acetaminophen hepatotoxicity.
Umbaugh DS; Jaeschke H
Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):363-375. PubMed ID: 33242385
[No Abstract] [Full Text] [Related]
8. Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work.
Suzuki A; Andrade RJ; Bjornsson E; Lucena MI; Lee WM; Yuen NA; Hunt CM; Freston JW
Drug Saf; 2010 Jun; 33(6):503-22. PubMed ID: 20486732
[TBL] [Abstract][Full Text] [Related]
9. Acetaminophen-related hepatotoxicity.
Bunchorntavakul C; Reddy KR
Clin Liver Dis; 2013 Nov; 17(4):587-607, viii. PubMed ID: 24099020
[TBL] [Abstract][Full Text] [Related]
10. An update on drug induced liver injury.
Rangnekar AS; Fontana RJ
Minerva Gastroenterol Dietol; 2011 Jun; 57(2):213-29. PubMed ID: 21587150
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of drug-induced liver injury as etiology for acute liver failure in Brazil.
Santos G; Figueira ERR; D'Albuquerque LAC; Lisboa PB; de Almeida MD; Filgueira NA; Boin I; Porta G; da Silva RCMA; Viana CFG; Faria LC; Alvares-da-Silva MR; de Moraes ACP; Morsoletto DBG; Codes L; Paraná R
Ann Hepatol; 2021; 23():100310. PubMed ID: 33508520
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of drug-induced liver injury: from bedside to bench.
Tujios S; Fontana RJ
Nat Rev Gastroenterol Hepatol; 2011 Apr; 8(4):202-11. PubMed ID: 21386809
[TBL] [Abstract][Full Text] [Related]
13. Current challenges and controversies in drug-induced liver injury.
Corsini A; Ganey P; Ju C; Kaplowitz N; Pessayre D; Roth R; Watkins PB; Albassam M; Liu B; Stancic S; Suter L; Bortolini M
Drug Saf; 2012 Dec; 35(12):1099-117. PubMed ID: 23137150
[TBL] [Abstract][Full Text] [Related]
14. Acetaminophen-Induced Liver Injury Alters Expression and Activities of Cytochrome P450 Enzymes in an Age-Dependent Manner in Mouse Liver.
Bao Y; Wang P; Shao X; Zhu J; Xiao J; Shi J; Zhang L; Zhu HJ; Ma X; Manautou JE; Zhong XB
Drug Metab Dispos; 2020 May; 48(5):326-336. PubMed ID: 32094214
[TBL] [Abstract][Full Text] [Related]
15. MRI-based preclinical discovery of DILI: A lesson from paracetamol-induced hepatotoxicity.
Grudzinski IP; Ruzycka M; Cieszanowski A; Szeszkowski W; Badurek I; Malkowska A; Bamburowicz-Klimkowska M
Regul Toxicol Pharmacol; 2019 Nov; 108():104478. PubMed ID: 31539568
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicity.
Du K; Xie Y; McGill MR; Jaeschke H
Expert Opin Drug Metab Toxicol; 2015; 11(11):1769-79. PubMed ID: 26190663
[TBL] [Abstract][Full Text] [Related]
17. The application of metabonomics to predict drug-induced liver injury.
O'Connell TM; Watkins PB
Clin Pharmacol Ther; 2010 Sep; 88(3):394-9. PubMed ID: 20668441
[TBL] [Abstract][Full Text] [Related]
18. Comparison of hepatic transcriptome profiling between acute liver injury and acute liver failure induced by acetaminophen in mice.
Li C; Ming Y; Hong W; Tang Y; Lei X; Li X; Mao Y
Toxicol Lett; 2018 Feb; 283():69-76. PubMed ID: 29174983
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib alleviates drug-induced liver injury by regulating CYP2E1 gene transcription.
Park WJ; Kim SY; Kim YR; Park JW
Int J Mol Med; 2016 Mar; 37(3):613-22. PubMed ID: 26797017
[TBL] [Abstract][Full Text] [Related]
20. Animal models of drug-induced liver injury.
McGill MR; Jaeschke H
Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):1031-1039. PubMed ID: 31007174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
